• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceINSYNC III MODEL 8042 AND INSYNC III MODEL 9981 APPLICATION SOFTWARE
Generic NameImplantable pulse generator, pacemaker (non-CRT)
ApplicantMEDTRONIC Inc.
8200 CORAL SEA STREET NE
MS MV S11
MOUNDS VIEW, MN 55112
PMA NumberP010015
Supplement NumberS005
Date Received03/04/2002
Decision Date02/25/2003
Product Code LWP 
Advisory Committee Cardiovascular
Supplement TypeNormal 180 Day Track
Supplement Reason Change Design/Components/Specifications/Material
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
APPROVAL FOR THE INSYNC III MODEL 8042 AND INSYNC III MODEL 9981 APPLICATION SOFTWARE WHICH IS INDICATED AS FOLLOWS: THE INSYNC III MODEL 8042 DEVICE IS INDICATED FOR THE REDUCTION OF SYMPTOMS OF MODERATE TO SEVERE HEART FAILURE (NYHA CLASS III OR IV), IN THOSE PATIENTS WHO REMAIN SYMPTOMATIC DESPITE STABLE, OPTIMAL MEDICAL THERAPY (AS DEFINED IN THE CLINICAL TRIALS SECTION), AND HAVE A LEFT VENTRICULAR EJECTION FRACTION <=35%, AND A QRS >=130 MS. RATE ADAPTIVE PACING IS PROVIDED FOR THOSE PATIENTS DEVELOPING A BRADYCARDIA INDICATION WHO MIGHT BENEFIT FROM INCREASED PACING RATES CONCURRENT WITH INCREASE IN ACTIVITY. DUAL CHAMBER AND ATRIAL TRACKING MODES ARE INDICATED FOR PATIENTS WHO MAY BENEFIT FROM MAINTENANCE OF AV SYNCHRONY.
-
-